Immunotherapy for Infectious Diseases
Immunotherapy for Infectious Diseases Immunotherapy for Infectious Diseases
Humoral Immunity 9 minal complement components, which punch holes in the cell wall, leading to an osmotic death. Complement components also facilitate phagocytosis by cells possessing a receptor for C3b, e.g., polymorphs. Mucosal protection. This is provided mainly by IgA and, to a lesser degree, IgG. IgA acts chiefly by inhibiting pathogens from gaining attachment to mucosal surfaces. This is a Fab function. Expulsion as a consequence of Mast cell degranulation. As a consequence of antigen, e.g., parasitic worms, binding to specific IgE attached to mast cells by their receptor for IgE Fc, there is release of mediators from the mast cell. This leads to contraction of smooth muscle, which can result in diarrhea, and expulsion of parasites. Here we see involvement of both Fab versus parasite antigen, with Fc anchoring the reacting participants. Precipitation of soluble antigens by immune complex formation. These consist of antigen linked to antibody. Depending on the ratio of antigen to antibody, they can be of varying size. When fixed at one site, they can be removed by phagocytic cells. They may also circulate prior to localization and removal and can fix complement. Here Fab and Fc are involved. Antibody-dependent cell-mediated cytotoxicity (ADCC). Antibodies bind to organisms via their Fab region. Large granular lymphocytes (natural killer [NK] cells)— attach via Fc receptors and kill these organisms not by phagocytosis but by release of toxic substances called perforins. Conferring immunity to the fetus by the transplantal passage of IgG. IgG is the only class (isotope) of immunoglobulin that can cross the placenta and enter the fetal circulation, where it confers immune protection. This is of great importance to the fetus in the first 3 months. The precise function of IgD is not known. It may serve as a maturation marker of B-lymphocytes. Primary and Secondary Responses When we are exposed to an antigen for the first time, there is a lag of several days before specific antibody becomes detectable. This antibody is IgM. After a short time, the antibody level declines. These are the main characteristics of the primary response. If at a later date we are reexposed to the same antigen, there is a far more rapid appearance of antibody, and in greater amounts. It is of the IgG class and remains detectable for months or years. These are the features of the secondary response. If at the same time we are reexposed to an antigen, we are exposed to a different antigen for the first time, the properties of the specific response to this antigen are those of the primary response, as shown in Fig. 4. The characteristics of the two responses may be outlined as follows: Primary response Slow in onset Low in magnitude Short lived IgM Secondary response Rapid in onset High in magnitude Long lived IgG (or IgA, or IgE)
10 Nara Fig. 4. Primary (dotted line, vaccination; IgM) and secondary (solid line, booster; IgG) antibody responses. Thus the secondary response requires the phenomenon known as class switching. This requires cooperation with T-cells of various types, which release cocktails of substances called cytokines. These cytokines induce gene rearrangements culminating in class switching (described below). This phenomenon is possible because the immune system possesses specific memory for antigens. It occurs because during the primary response, some B-lymphocytes, in addition to those differentiating into antibody-secreting plasma cells, become memory cells, which are long lived. GENERATION OF ANTIBODY DIVERSITY A major question is how antibodies recognize so many different epitopes. The antigen-combining site of the antibody molecule is in the variable region of Fab. Actually, this site is even more variable than the immediately adjacent sites and is known as the hypervariable region. The bond with antigen is of a physical, non-covalent nature. As mentioned before, variable (V), and constant (C) regions are genetically encoded. If we bear in mind that we need to be capable of responding to something on the order of 1018 antigens, we can appreciate the need for the enormous number of genes necessary to provide this. In fact, the amount of DNA that this would involve would be quite profligate, and nature has solved this problem very ingeniously by a neat little trick. In the germline DNA, the V genes encoding the antigen-combining sites need to combine with the C genes. Additional interposed genes bring about diversity of speci-
- Page 1 and 2: Immunotherapy for Infectious Diseas
- Page 3 and 4: In f e c t i o u s . D i s e a s e
- Page 5 and 6: © 2002 Humana Press Inc. 999 River
- Page 7 and 8: vi Preface I am grateful to all of
- Page 9 and 10: viii Contents 11 Passive Immunother
- Page 11 and 12: x Contributors BARBARA G. MATTHEWS,
- Page 14 and 15: From: Immunotherapy for Infectious
- Page 16 and 17: Humoral Immunity 5 Fig. 1. Humoral
- Page 18 and 19: Humoral Immunity 7 Table 1 Properti
- Page 22 and 23: Humoral Immunity 11 ficity. In ligh
- Page 24 and 25: Humoral Immunity 13 Fig. 7. VDJ joi
- Page 26 and 27: Humoral Immunity 15 Fig. 9. Messeng
- Page 28 and 29: Humoral Immunity 17 In contrast to
- Page 30 and 31: Humoral Immunity 19 advantage to tr
- Page 32 and 33: Humoral Immunity 21 32. Allman DM,
- Page 34 and 35: Some Basic Cellular Immunology Prin
- Page 36 and 37: Cellular Immunology Principles 25 i
- Page 38 and 39: Cellular Immunology Principles 27 s
- Page 40 and 41: Cellular Immunology Principles 29 d
- Page 42 and 43: Cellular Immunology Principles 31 f
- Page 44 and 45: Cellular Immunology Principles 33 F
- Page 46 and 47: Cellular Immunology Principles 35 R
- Page 48 and 49: Cellular Immunology Principles 37 1
- Page 50 and 51: INTRODUCTION Immune Defense at Muco
- Page 52 and 53: Immune Defense at Mucosal Surfaces
- Page 54 and 55: Immune Defense at Mucosal Surfaces
- Page 56 and 57: Immune Defense at Mucosal Surfaces
- Page 58 and 59: Immune Defense at Mucosal Surfaces
- Page 60 and 61: Immune Defense at Mucosal Surfaces
- Page 62 and 63: Immune Defense at Mucosal Surfaces
- Page 64 and 65: Immune Defense at Mucosal Surfaces
- Page 66 and 67: Immune Defense at Mucosal Surfaces
- Page 68 and 69: Immune Defense at Mucosal Surfaces
Humoral Immunity 9<br />
minal complement components, which punch holes in the cell wall, leading to an<br />
osmotic death. Complement components also facilitate phagocytosis by cells possessing<br />
a receptor <strong>for</strong> C3b, e.g., polymorphs.<br />
Mucosal protection. This is provided mainly by IgA and, to a lesser degree, IgG.<br />
IgA acts chiefly by inhibiting pathogens from gaining attachment to mucosal surfaces.<br />
This is a Fab function.<br />
Expulsion as a consequence of Mast cell degranulation. As a consequence of antigen,<br />
e.g., parasitic worms, binding to specific IgE attached to mast cells by their receptor<br />
<strong>for</strong> IgE Fc, there is release of mediators from the mast cell. This leads to contraction<br />
of smooth muscle, which can result in diarrhea, and expulsion of parasites. Here we<br />
see involvement of both Fab versus parasite antigen, with Fc anchoring the reacting<br />
participants.<br />
Precipitation of soluble antigens by immune complex <strong>for</strong>mation. These consist of<br />
antigen linked to antibody. Depending on the ratio of antigen to antibody, they can be<br />
of varying size. When fixed at one site, they can be removed by phagocytic cells. They<br />
may also circulate prior to localization and removal and can fix complement. Here Fab<br />
and Fc are involved.<br />
Antibody-dependent cell-mediated cytotoxicity (ADCC). Antibodies bind to organisms<br />
via their Fab region. Large granular lymphocytes (natural killer [NK] cells)—<br />
attach via Fc receptors and kill these organisms not by phagocytosis but by release of<br />
toxic substances called per<strong>for</strong>ins.<br />
Conferring immunity to the fetus by the transplantal passage of IgG. IgG is the only<br />
class (isotope) of immunoglobulin that can cross the placenta and enter the fetal circulation,<br />
where it confers immune protection. This is of great importance to the fetus<br />
in the first 3 months. The precise function of IgD is not known. It may serve as a maturation<br />
marker of B-lymphocytes.<br />
Primary and Secondary Responses<br />
When we are exposed to an antigen <strong>for</strong> the first time, there is a lag of several days<br />
be<strong>for</strong>e specific antibody becomes detectable. This antibody is IgM. After a short time,<br />
the antibody level declines. These are the main characteristics of the primary response.<br />
If at a later date we are reexposed to the same antigen, there is a far more rapid appearance<br />
of antibody, and in greater amounts. It is of the IgG class and remains detectable<br />
<strong>for</strong> months or years. These are the features of the secondary response. If at the same<br />
time we are reexposed to an antigen, we are exposed to a different antigen <strong>for</strong> the first<br />
time, the properties of the specific response to this antigen are those of the primary<br />
response, as shown in Fig. 4.<br />
The characteristics of the two responses may be outlined as follows:<br />
Primary response<br />
Slow in onset<br />
Low in magnitude<br />
Short lived<br />
IgM<br />
Secondary response<br />
Rapid in onset<br />
High in magnitude<br />
Long lived<br />
IgG (or IgA, or IgE)